Adverse Pregnancy Outcomes With Isoniazid Preventive Therapy in HIV
Findings from this phase 4 study call for a re-evaluation of the current WHO and CDC guidelines of isoniazid preventive therapy for the prevention of tuberculosis in pregnant women with HIV.